Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The clinical comparison of skeletal imaging agents

  • 23 Accesses

  • 2 Citations

Abstract

99mTc-methylene diophosphonate from two manufacturers was compared with 99mTc-ethane hydroxy diphosphonate in a randomised trial to assess the relative blood clearances and the subsequent image quality. The 99mTc-methylene diphosphonate preparations were found to be superior with respect to both blood clearance and subjectively assessed image quality, particularly when the interval between injection and scanning was three hours. Bone/soft tissue ratios did not mirror the highly significant qualitative comparisons of image quality.

This is a preview of subscription content, log in to check access.

References

  1. Citrin, D.L., Bessent, R.G., Tuohy, J.B., Elms, S.T., McGinlay, E., Greig, W.R., Blumgart, L.H.: A comparison of phosphate bone-scanning in normal subjects and patients with malignant disease. Br. J. Radiol. 48 118–121 (1975)

  2. Rudd, T.G., Allen, D.R., Hartnett, D.E.: Tc99mmethylene diphosphonate versus Tc99mpyrophosphate: Biologic and clinical comparison. J. Nucl. Med. 18 872–876 (1977)

  3. Subramanian, G., McAfee, J.G.: A new complex of 99mTc for skeletal imaging. Radiology 99 192–196 (1971)

  4. Subramanian, G., McAfee, J.G., Blair, R.J., Kallfelz, F.A., Thomas, F.D.: Tc99mmethylene diphosphonate versus Tc99mpyrophosphate: Biologic and clinical comparison. J. Nucl. Med. 16 744–755 (1975)

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Adams, F.G., Horton, P.W. & Stenhouse, G. The clinical comparison of skeletal imaging agents. Eur J Nucl Med 5, 257–260 (1980). https://doi.org/10.1007/BF00271908

Download citation

Keywords

  • Public Health
  • Image Quality
  • Nuclear Medicine
  • Randomise Trial
  • Imaging Agent